MAL2, a novel raft protein of the MAL family, is an essential component of the machinery for transcytosis in hepatoma HepG2 cells by de Marco, María C. et al.
 
JCB
 

 
 The Rockefeller University Press, 0021-9525/2002/10/37/8 $5.00
The Journal of Cell Biology, Volume 159, Number 1, October 14, 2002 37–44
http://www.jcb.org/cgi/doi/10.1083/jcb.200206033 37
 
Report
 
MAL2, a novel raft protein of the MAL family, is an 
essential component of the machinery for transcytosis 
in hepatoma HepG2 cells
 
María C. de Marco,
 
1
 
 Fernando Martín-Belmonte,
 
1
 
 Leonor Kremer,
 
2
 
 Juan P. Albar,
 
2
 
 Isabel Correas,
 
1
 
 
Jean P. Vaerman,
 
3
 
 Mónica Marazuela,
 
4
 
 Jennifer A. Byrne,
 
5
 
 and Miguel A. Alonso
 
1
 
1
 
Centro de Biología Molecular “Severo Ochoa” and 
 
2
 
Departamento de Immunología and Oncología, Centro Nacional de Biotecnología, 
Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Cientíﬁcas, Cantoblanco, 28049 Madrid, Spain
 
3
 
Christian de Duve Institute of Cellular Pathology, Université Catholique de Louvain, B-1200 Brussels, Belgium
 
4
 
Departamento de Endocrinología, Hospital de la Princesa, 28006 Madrid, Spain
 
5
 
Oncology Research Unit and the University of Sidney Department of Pediatrics and Child’s Health, The Children’s Hospital, 
Westmead, NSW, 2145, Australia
 
ranscytosis is used alone (e.g., hepatoma HepG2 cells)
or in combination with a direct pathway from the Golgi
(e.g., epithelial MDCK cells) as an indirect route for
targeting proteins to the apical surface. The raft-associated
MAL protein is an essential element of the machinery for the
direct route in MDCK cells. Herein, we present the functional
 
characterization of MAL2, a member of the MAL pro-
tein family, in polarized HepG2 cells. MAL2 resided selec-
tively in rafts and is predominantly distributed in a compart-
ment localized beneath the subapical F-actin cytoskeleton.
MAL2 greatly colocalized in subapical endosome structures
T
 
with transcytosing molecules en route to the apical surface.
Depletion of endogenous MAL2 drastically blocked trans-
cytotic transport of exogenous polymeric immunoglobulin
receptor and endogenous glycosylphosphatidylinositol-
anchored protein CD59 to the apical membrane. MAL2
depletion did not affect the internalization of these molecules
but produced their accumulation in perinuclear endosome
elements that were accessible to transferrin. Normal trans-
cytosis persisted in cells that expressed exogenous MAL2
designed to resist the depletion treatment. MAL2 is therefore
essential for transcytosis in HepG2 cells.
 
Introduction
 
Transcellular transport of external material involves a special-
ized pathway known as transcytosis, consisting of endocytosis
of cargo on one side of the epithelial barrier, its vectorial
traffic in vesicular carriers across the cell, and subsequent
delivery to the other side. In addition to translocating external
material, the transcytotic pathway is used as an indirect
route for targeting membrane proteins to the apical surface
via the basolateral membrane. Despite considerable advances in
the elucidation of transcytosis steps (Mostov et al., 2000), little
is known about the integral protein machinery implicated in
the postendocytic events and in the organization of specialized
subcellular compartments involved.
Simultaneous to the indirect transcytotic route, polarized
epithelial MDCK cells transport newly synthesized proteins
to the apical surface directly from the Golgi. A direct transport
pathway appears to be mediated by integration of cargo protein
into specialized glycolipid and cholesterol-enriched membrane
microdomains or rafts that subsequently originate vesicular
carriers destined for the apical surface (Simons and Wandinger-
Ness, 1990). MAL is a nonglycosylated integral membrane
protein of 17 kD containing four hydrophobic segments
(Alonso and Weissman, 1987) that exclusively resides in
rafts (Puertollano et al., 1999). Using MDCK cells whose
endogenous MAL was depleted, an essential role has been
demonstrated for MAL as an element of the machinery
necessary for transport of apical proteins through the direct
route (Cheong et al., 1999; Puertollano et al., 1999; Martín-
Belmonte et al., 2000, 2001).
MAL is the founder member of a family of proteins (the
MAL protein family) with structural and biochemical simi-
larities (Pérez et al., 1997). MAL2 is a novel member of the
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MAL family identified recently (Wilson et al., 2001). In our
initial experiments, we detected 
 
MAL2
 
 gene expression in
hepatoma HepG2 cells and in the epithelial MDCK and
Caco-2 cell lines, all of which use the transcytotic pathway
to a greater (HepG2) or lesser extent (MDCK and Caco-2)
to target membrane proteins to the apical surface. Since we
considered the hypothesis that MAL2 may act as machinery
for transcytosis plausible, we undertook a study of MAL2
function in hepatoma HepG2 cells, which are a paradigm
for the study of the transcytotic pathway in a cellular con-
text deprived of other apical routes of transport for single
transmembrane and glycosylphosphatidylinositol (GPI)*-
anchored proteins (Bastaki et al., 2002).
 
Results and discussion
 
The MAL2 protein resides in lipid rafts in hepatoma 
HepG2 cells
 
Human MAL2 is a 176-residue (
 
M
 
r 
 
 
 
19,000) protein with
four putative transmembrane domains (Fig. 1 A) and
 
 
 
36% identity with MAL at the amino acid level (Wilson
et al., 2001). To identify a suitable human model cell sys-
tem for studying MAL2, we performed Northern blot anal-
yses using a panel of human cell lines. Canine MDCK cells
were analyzed in parallel. Fig. 1 B shows that MAL2
mRNA species were expressed in hepatoma HepG2 cells
and intestinal Caco-2 cells, consistent with the reported ex-
pression of MAL2 mRNA in the corresponding tissues
(Wilson et al., 2001). MAL2 transcripts were undetectable
in all other human cell lines analyzed. Canine MDCK cells
 
were the only cell line positive for both MAL and MAL2
mRNA expression.
The NH
 
2
 
-terminal peptide indicated in Fig. 1 A was cho-
sen to generate a mAb to human MAL2. The 9D1 hy-
bridoma clone was identified as producing antibodies to
MAL2 by the selective detection of MAL2 in COS-7 cells
transiently expressing c-Myc–tagged MAL2 (MAL2-Myc)
(see Fig. 4 A) but not in untransfected cells (Fig. 1 C).
Consistent with the observed expression of the 
 
MAL2
 
 gene
(Fig. 1 B), mAb 9D1 recognized endogenous MAL2 in
HepG2 and Caco-2 cells but not in Jurkat or HeLa cells
(Fig. 1 D). No cross-reactivity was observed with the canine
protein in MDCK cells (unpublished data). Contrary to
observations of exogenous MAL2 in COS-7 cells, the en-
dogenous MAL2 protein in HepG2 and Caco-2 cells mi-
grated as a mixture of glycosylated (
 
M
 
r 
 
  
 
30–40,000) and
unglycosylated species (
 
M
 
r 
 
  
 
19,000). The observation that
MAL2 glycosylation was sensitive to treatment with en-
doglycosydase H (unpublished data) supports the use of the
unique consensus site of 
 
N
 
-glycosylation present in the
MAL2 molecule (Fig. 1 A). Fig. 1 E shows that endogenous
MAL2 was selectively detected in the raft fraction of
HepG2 cells. As controls, we observed that raft fractions
contained the GPI-anchored protein CD59 and excluded
the transferrin (Tf) receptor (TfR), which were taken as
representatives of markers associated and nonassociated
with lipid rafts, respectively.
 
Subcellular distribution of MAL2 in polarized 
HepG2 cells
 
Hepatocytes are specialized polarized cells whose plasma
membrane is subdivided into bile canalicular and sinusoidal
domains, equivalent to the apical and basolateral surfaces,
 
*Abbreviations used in this paper: GPI, glycosylphosphatidylinositol; pIgR,
polymeric immunoglobulin receptor; Tf, transferrin; TfR, Tf receptor.
Figure 1. Characterization of human 
MAL2 with a newly generated 
monoclonal antibody. (A) Schematic 
model of the predicted structure of MAL2 
with indication of the position of the 
consensus N-glycosylation site present 
in the molecule and the NH2-terminal 
peptide selected for the preparation of 
antibodies. (B) Expression of the MAL2 
gene in different cell lines. Total RNA from 
the indicated cell lines was hybridized 
to DNA probes specific to MAL2, MAL, 
or  -actin. (C) Characterization of a novel 
mAb to MAL2. To assay the specificity 
of mAb 9D1, protein extracts from 
untransfected (U) or from transfected (T) 
COS-7 cells transiently expressing MAL2 
tagged with the c-Myc 9E10 epitope 
were subjected to immunoblot analysis 
with either mAb 9D1 or the antitag mAb 
9E10. Since COS-7 cells are negative for 
MAL2 gene expression (unpublished 
data), no reaction was observed with 
endogenous proteins of COS-7 cells. 
(D) mAb 9D1 detects endogenous MAL2. Membrane fractions from the indicated cell lines were subjected to immunoblot analysis with 
anti-MAL2 mAb 9D1. (E) Identification of endogenous MAL2 in lipid raft fractions in HepG2 cells. Cells were extracted with 1% Triton X-100 
at 4 C and subjected to centrifugation to equilibrium in sucrose density gradients. Aliquots from each fraction were analyzed by immunoblotting 
with anti-MAL2 mAb 9D1, and antibodies to CD59, used as a raft marker, and to TfR, a transmembrane protein excluded from rafts. Fractions 
1–4 represent the 40% sucrose layer and contain the bulk of cellular membranes and cytosolic proteins, whereas fractions 5–12 represent the 
5–30% sucrose layer and contain the rafts. 
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respectively, of polarized epithelia. The canalicular surfaces
of apposing hepatocytes delimit the bile canaliculi, which
are small channels involved in bile secretion, whereas the si-
nusoidal surfaces face specialized capillary-like vessels, re-
ferred to as sinusoids, and establish contacts between adja-
cent cells. The species specificity of mAb 9D1 to the human
MAL2 protein, the ability of HepG2 cells to polarize in
vitro delimiting closed spaces reminiscent of bona fide bile
canaliculi (Sormunen et al., 1993), and the fact that polar-
ized trafficking in this cell line is simpler than in other cell
lines (Bastaki et al., 2002) led us to choose HepG2 cells for
further study.
The canalicular membrane is highly enriched with actin
filaments, and so F-actin staining with fluorescent phalloi-
din can be used to visualize this membrane subdomain
(Zegers et al., 1998). 48 h after plating, the percentage of
HepG2 cells forming bile canaliculi was estimated to be
 
 
 
30% as assayed by F-actin staining. We have confined our
analysis exclusively to this polarized cell population. Fig. 2 A
shows that MAL2 was mostly detected in the canalicular
membrane region as revealed by double-label immunofluo-
 
rescence analysis of MAL2 and F-actin and parallel imaging
under a phase–contrast microscope. In the nonpolarized cell
population, MAL2 was distributed in the perinuclear region
(unpublished data). Confocal microscopic analysis (Fig. 2 B)
in a horizontal x,y plane shows that MAL2 mostly distrib-
uted in polarized cells beneath the actin belt that surrounds
the bile canaliculus. In addition, the presence of low levels of
MAL2 in perinuclear vesicular structures was observed in
some of the confocal planes. The vertical x,z view shows
that, although actin is also detected inside the bile canalicu-
lar space, consistent with the presence of actin in microvilli
protruding in the bile canaliculi, MAL2 was only found be-
neath the canalicular actin cytoskeleton. Consistent with the
distribution observed in polarized HepG2 cells, MAL2 was
exclusively detected at the bile canalicular membrane region
by immunohistochemical analysis of human liver tissue sec-
tions (Fig. 2 C).
We next compared the distribution of MAL2 with those
of two types of transcytosing molecules known to pass
through apically localized recycling endosome structures en
route to the canalicular surface (Schell et al., 1992; Apodaca
Figure 2. Distribution of MAL2 in polarized HepG2 cells and human liver. (A) HepG2 cells were double stained for MAL2 and F-actin and 
analyzed using a conventional fluorescence microscope. A phase–contrast image from the same field was taken to visualize the bile canaliculus 
(arrowhead). (B) HepG2 cells were double stained for MAL2 and F-actin and analyzed by confocal microscopy. Optical horizontal x,y and 
vertical x,z sections corresponding to planes in the middle of the cell or in the center of the bile canaliculus, respectively, are shown. (C) Liver 
tissue sections were subjected to immunohistochemical analysis with anti-MAL2 mAb 9D1 and counterstained with hematoxylin to visualize 
nuclei. Reactivity was found exclusively in the bile canaliculi, which appear as dots or lines depending on whether they were sectioned 
transversely (filled arrowheads) or longitudinally (open arrowheads) and absent from the sinusoidal membrane (asterisks). The inset shows at 
higher magnification a transversely sectioned bile canaliculus stained for MAL2. Bars, 5  m. 
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et al., 1994). First, we followed the transport of polymeric
IgA bound to the polymeric immunoglobulin receptor
(pIgR), as a prototypical transcytotic system (Mostov and
Deitcher, 1986), using HepG2 cells that stably expressed
the human pIgR molecule. The second system analyzed
consisted of the basolateral-to-apical transcytosis of the en-
dogenous GPI-anchored molecule CD59. IgA and anti-
CD59 antibodies were bound to their respective target mol-
ecule on the surface of HepG2 cells at 4
 
 
 
C. The two ligands
were internalized and concentrated in peripheral basolateral
endosomes upon incubation at 37
 
 
 
C, and after 30 min, they
had mostly accumulated in apical endosomes and colocal-
ized with endogenous MAL2. After 60 min, both molecules
were detected in the bile canaliculus (Fig. 3, A and B). No-
codazole treatment impedes transport of pIgR from periph-
eral basolateral early endosomes to downstream compart-
ments of the transcytotic pathway but does not affect IgA
internalization in MDCK cells (Hunzinker et al., 1990;
Apodaca et al., 1994). Transcytotic transport to the canalic-
ular membrane is sensitive to incubation of cells at 18
 
 
 
C in
such a way that transcytosing molecules accumulate in api-
cal recycling endosomes and further transport to the canalic-
ular surface is reduced (Apodaca et al., 1994; van IJzen-
doorn and Hoekstra, 1998). To look for better conditions
of colocalization of MAL2 and transcytosing IgA, HepG2
cells with surface-bound IgA were incubated for 60 min at
37
 
 
 
C in the presence of nocodazole to accumulate IgA in
peripheral basolateral early endosomes and then for 120 min
at 18
 
 
 
C in the absence of the drug to allow synchronized
trafficking of the complex to apical recycling endosomes,
while simultaneously preventing its exit therefrom. Fig. 3 C
shows a nearly complete colocalization of MAL2 with IgA
under these conditions.
 
Depletion of endogenous MAL2 in HepG2 cells using 
an antisense oligonucleotide-based strategy
 
To address directly the possible role of MAL2 in transcytotic
transport, we designed a 19-mer phosphorothioate oligonu-
cleotide complementary to the sequence surrounding the
AUG translation initiation site of human MAL2 mRNA
(Fig. 4 A) for use as an antisense MAL2 oligonucleotide
(MAL2/AS). As a control oligonucleotide, we used the anti-
sense oligonucleotide MAL/AS used previously for depleting
endogenous MAL from MDCK (Puertollano et al., 1999).
Although the control oligonucleotide or other oligonucle-
otides with the same composition as MAL2/AS but different
sequence did not affect MAL2 levels, transfection of oligo-
nucleotide MAL2/AS greatly diminished the amount of en-
dogenous MAL2 in HepG2 cells (Fig. 4 B). The MAL2 lev-
els obtained in cells transfected with oligonucleotide MAL2/
AS were routinely 2–10% of those found in control cells.
The levels of CD59 and the TfR chosen as representatives of
proteins included in or excluded from lipid rafts, respec-
tively, were not affected by this treatment.
Figure 3. Double label immunofluorescence analysis of MAL2 and trancytosing molecules. (A) HepG2 cells stably expressing pIgR were 
incubated with IgA for 30 min at 4 C, washed, and placed at 37 C for the indicated times. Cells were then subjected to double label 
immunofluorescence analysis as indicated to detect MAL2 and IgA or were triply labeled to also detect F-actin. (B) HepG2 cells were incubated 
for 30 min at 4 C with anti-CD59 mAb, washed, and incubated at 37 C for the indicated times. Cells were then subjected to double label 
immunofluorescence analysis to detect MAL2 and CD59. (C) HepG2 cells stably expressing pIgR were incubated with IgA for 30 min at 4 C, 
washed, and incubated at 37 C for 60 min in the presence of 33  M nocodazole. Cells were then washed, incubated for 120 min at 18 C in 
the absence of nocodazole, and subjected to double label immunofluorescence analysis to detect MAL2 and IgA. In all cases, the images 
presented are the composite projection of all the frames obtained by confocal microscopic analysis of the cells. Bars, 5  m. 
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As a control for the specificity of the effect of oligonucle-
otide MAL2/AS, we designed different DNA constructs
producing MAL2 transcripts with an altered 5
 
 
 
 untrans-
lated region and modifications in the first nucleotides of the
coding region (silent substitutions, deletions, or insertions)
that prevent pairing with the antisense MAL2/AS oligonu-
cleotide. The constructs encoded an intact MAL2 protein
(MAL2-e) or MAL2 proteins modified by either a five–
amino acid deletion (MAL2-
 
 
 
N) or the addition of the
Myc epitope (MAL2-Myc) in the sequence contiguous with
the initial methionine residue. The modifications intro-
duced did affect neither the glycosylation nor the incor-
poration of the molecule into rafts (unpublished data).
HepG2 cells that stably expressed each of the MAL2 pro-
teins were used to assay the effect of the antisense MAL2/
AS oligonucleotide on the levels of exogenous and endoge-
nous MAL2. We found MAL2 expression in the presence of
antisense oligonucleotide MAL2/AS in all the transfectants
as assayed by immunoblot and immunofluorescence analy-
ses (Fig. 4 C). Although the staining and distribution of
MAL2 was unaltered by transfection with the control oligo-
nucleotide, the antisense oligonucleotide MAL2/AS ren-
dered MAL2 levels almost undetectable in normal HepG2
cells. In the transfectants treated with control oligonucle-
otides, the exogenous protein presented a distribution iden-
 
tical to that of the endogenous protein. However, under
conditions of endogenous MAL2 depletion only the trans-
fectants expressing the intact protein (HepG2/MAL2-e
cells) presented the typical subcanalicular distribution of
endogenous MAL2.
 
MAL2 depletion blocks transcytosis of pIgR and CD59 
in HepG2 cells
 
Fig. 5 A shows that internalization of IgA in HepG2 cells
was not affected in cells treated with the antisense MAL2/AS
oligonucleotide despite the reduction of MAL2 levels, since
IgA accumulated in small peripheral basolateral endosome
structures in the continuous presence of nocodazole, regard-
less of the levels of MAL2. However, whereas pIgR-IgA
moved to apical endosomes and the bile canaliculi after re-
moval of nocodazole and incubation at 37
 
 
 
C in the cells
transfected with the control oligonucleotide, the complex
mostly shifted to large endosomes with perinuclear location
and accumulated in this compartment in cells with depleted
levels of MAL2. The accumulated IgA colocalized partially
with Tf in the same structures under conditions that al-
low trafficking of Tf from basolateral early endosomes to
downstream compartments, including perinuclear endosomes
(Fig. 5 B). Therefore, MAL2 is not required for transport of
pIgR-IgA from the sinusoidal membrane to peripheral and
Figure 4. Depletion of endogenous 
MAL2 by transfection with an antisense 
phosphorothioate oligonucleotide. 
(A) The sequence of the antisense oligo-
nucleotide used in MAL2 depletion 
experiments (MAL2/AS) and its alignment 
with wild-type MAL2 mRNA and the 
recombinant MAL2 mRNA species 
expressed in HepG2 cells are shown. 
Note that the changes introduced in the 
recombinant MAL2 transcripts prevent 
pairing with oligonucleotide MAL2/AS. 
The singly underlined residues correspond 
to sequences in the vector located 
immediately upstream of the inserted 
cDNA sequence. The doubly underlined 
residues in the coding sequence indicate 
nucleotides replaced by an equivalent 
triplet (MAL2-e), deleted (MAL2- N) or 
added (MAL2-Myc). (B) HepG2 cells 
were transfected with control or MAL2/AS 
oligonucleotide and incubated at 37 C. 
After 72 h, cell extracts were subjected 
to immunoblot analysis with anti-MAL2 
mAb 9D1 and with anti-CD59 and TfR 
antibodies. (C) Normal HepG2 cells or 
cells stably expressing the indicated 
exogenous products were transfected 
with control or MAL2/AS oligonucleotide 
and incubated at 37 C. After 72 h, cells 
were processed for immunoblot and 
immunofluorescence analyses with 
anti-MAL2 mAb, which recognizes both 
endogenous and exogenous MAL2 
species. For simplicity, only the part of 
the blots corresponding to the unglycosylated MAL2 species is shown. Note that due to the deletion (MAL2- N) or insertion (MAL2-Myc) of 
sequences the modified MAL2 proteins migrates faster or slower, respectively, than endogenous MAL2. Several independent cell clones ( 3) 
from each type of cell transfectant were assayed and gave the same results. The immunofluorescence images correspond to the composite 
projection of all the frames obtained by confocal microscopic analysis of the cells. Bar, 5  m. 
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perinuclear endosomes but is essential for exit of pIgR-IgA
from perinuclear endosomes to transit to downstream apical
endosome compartments.
To confirm that MAL2 has a more general role in transcy-
tosis, we examined the effect of MAL2 depletion in transcy-
tosis of CD59. In addition, to demonstrate that the effects
on transcytosis were due to MAL2 depletion and not to spu-
rious effects of the antisense MAL2/AS oligonucleotide, we
took advantage of the selectivity of MAL2/AS in blocking
expression of endogenous but not exogenous MAL2 in
HepG2 cells stably expressing recombinant MAL2 proteins.
Fig. 5 C shows that CD59 transcytosis was also blocked by
MAL2 depletion and that the exogenous expression of intact
MAL2 resistant to the depletion treatment allowed normal
transcytotic transport of CD59 despite transfection with the
antisense MAL2/AS oligonucleotide. Consistent with their
dispersal in cells whose endogenous MAL2 was depleted
(Fig. 4 C), the MAL2 proteins with a modified NH
 
2
 
 termi-
nus were not able to substitute endogenous MAL2 in CD59
transcytosis (unpublished data).
 
MAL and MAL2 as elements of the integral membrane 
protein machinery for raft-mediated trafficking
 
Although the use of direct routes of transport to the apical
membrane appears to be restricted, the indirect transcytotic
route constitutes a common pathway for most polarized
 
cells. The fact that MAL and MAL2 are expressed and access
rafts independently of each other suggests that the two pro-
teins perform distinct tasks in the cell. In epithelial MDCK
cells, MAL depletion causes accumulation at the Golgi re-
gion of cargo normally delivered to the apical membrane
through the direct route (Cheong et al., 1999; Martín-Bel-
monte et al., 2001). MAL2 depletion in HepG2 cells blocks
apical transport of transcytosing molecules at perinuclear en-
dosomes. Therefore, both MAL and MAL2 are members of
the machinery of polarized transport: MAL plays an essential
role in the direct apical transport pathway, whereas our re-
sults presented here show that MAL2 is required for the in-
direct transcytotic route.
 
Materials and methods
 
Materials
 
The hybridoma producing mAb 9E10 to the c-Myc epitope was purchased
from the American Type Culture Collection. The rabbit polyclonal anti-
bodies to human Tf and pIgR were from Dako, and those to the human TfR
were from Zymed Laboratories. Mouse mAb to CD59 (MEM-43/5, IgG2a)
was provided by Dr. V. Horejsi (Institute of Molecular Genetics, Prague,
Czech Republic). Fluorescent phalloidin was obtained from Molecular
Probes. Nocodazole and human Tf were purchased from Sigma-Aldrich.
 
Cell culture conditions, DNA constructs, and transfections
 
Human hepatoma HepG2 cells (Sormunen et al., 1993) were grown on
Petri dishes in DME supplemented with 10% FBS (GIBCO-BRL), penicillin
(50 U/ml), and streptomycin (50 
 
 
 
g/ml) at 37
 
 
 
C in an atmosphere of 5%
Figure 5. MAL2 depletion blocks 
transcytosis of both pIgR-IgA and 
CD59 in HepG2 cells. (A) HepG2 cells 
stably expressing pIgR were transfected 
with either control or MAL2/AS oligo-
nucleotide, plated, and incubated at 
37 C for 72 h. Cells were incubated in 
the presence of IgA for 60 min at 4 C 
and then were treated with 33  M 
nocodazole for 60 min at 37 C. After 
removal of nocodazole (0 min), cells 
were incubated at 37 C for 120 min in the 
absence of the drug. Cells were stained 
with anti-IgA antibodies to determine 
the distribution of IgA. In parallel, mAb 
9D1 was used to visualize the effect of the 
antisense oligonucleotide on MAL2 levels 
(unpublished data). One representative 
experiment out of ten performed is shown. 
(B) HepG2 cells in which IgA was 
accumulated in perinuclear endosomes 
by depletion of MAL2 were incubated 
with Tf for 10 min at 37 C, washed, 
and incubated for 10 min at 37 C to 
allow trafficking of internalized Tf to 
downstream compartments. Cells were 
then subjected to double label immuno-
fluorescence analysis to detect IgA and 
Tf. (C) Normal HepG2 cells or HepG2 
cells stably expressing MAL2-e were 
transfected with either control or MAL2/AS 
oligonucleotide, plated, and incubated 
at 37 C for 72 h. After binding of 
anti-CD59 mAb at 4 C, cells were 
incubated at 37 C for 60 min and fixed. 
After permeabilization, cells were stained with secondary antibodies to visualize the antibody bound CD59 complexes. One representative 
experiment out of six performed is shown. In all cases, the images presented are the composite projection of all the frames obtained by 
confocal microscopic analysis of the cells. Bars, 5  m. 
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CO
 
2
 
/95% air. The 19-mer phosphorothioate oligonucleotide MAL2/AS
(5
 
 
 
-GGCCGACATGCTGCCGCTG-3
 
 
 
) (Isogen Bioscience BV) was de-
signed to anneal to endogenous MAL2 mRNA. The phosphorothioate oli-
gonucleotide MAL/AS used in control experiments has been described
previously (Puertollano et al., 1999). Oligonucleotides (50 
 
 
 
M) were in-
troduced into HepG2 cells by electroporation of 2 
 
 
 
 10
 
6
 
 cells resus-
pended in 200 
 
 
 
l of culture medium buffered with 10 mM Hepes, pH 7.0,
and supplemented with 10% FBS and with 20 
 
 
 
g of salmon sperm DNA
as a carrier. The cell suspension was placed in a 4-mm gap cuvette, and
the transfection was performed with the equipment set up at 200 V, 480
ohms, and 960 
 
 
 
F. Under these conditions, the actual pulse length, as de-
fined by the equipment manufacturer, ranged from 40 to 50 ms. After
electroporation, 1 ml of culture medium with 10% FBS was added, and
the cells were left at room temperature for 10 min. Finally, cells were
plated out at subconfluent levels. Parallel experiments to measure the up-
take of oligonucleotides using phosphorothioate oligonucleotides labeled
at the 5
 
 
 
 end with Texas red indicated that the transfection efficiencies
varied between 95–99% of cells as assayed by immunofluorescence anal-
ysis (unpublished data).
To express modified MAL2 mRNA species, the cDNA containing the
coding sequence of MAL2 (Wilson et al., 2001) was amplified by PCR us-
ing 5
 
 
 
 oligonucleotide primers containing sequences designed with the ap-
propriate modifications and an oligonucleotide primer specific for its 3
 
 
 
end. The amplification products were cloned into the pCR3.1 DNA eu-
karyotic expression vector (Invitrogen). The cDNA construct expressing
human pIgR was provided by Dr. P. Brandtzaeg (University of Oslo, Oslo,
Norway). Transfection of HepG2 cells with plasmid DNA was performed
by electroporation using an Electro Cell Manipulator 600 (BTX). Stable
transfectants were selected by treatment with 0.5 mg/ml G-418 sulfate
(Sigma-Aldrich) for at least 4 wk after transfection. Cell clones were
screened by immunofluorescence analysis and/or reverse transcription
coupled to the PCR using oligonucleotide primers corresponding to se-
quences in the vector flanking the cloning sites used. The clones that
proved to be positive were maintained in drug-free medium.
 
Preparation of monoclonal antibodies to MAL2
 
The peptide corresponding to amino acids 13–28 of the MAL2 molecule
was coupled to keyhole limpet hemocyanin. Spleen cells from mice im-
munized with the peptide were fused to myeloma cells and plated onto
microtiter plates. The hybridoma clone 9D1, which produced antibodies
that recognized MAL2 in membrane extracts from COS-7 cells transiently
expressing tagged MAL2, was selected.
 
Northern blot analysis
 
20 
 
 
 
g total RNA from the indicated cell lines were denatured in 50% form-
amide and 2.2 M formaldehyde at 65
 
 
 
C, electrophoresed, and trans-
ferred to nylon membranes. RNA samples were hybridized under standard
conditions to the indicated 
 
32
 
P-labeled cDNA probes. Final blot washing
conditions were 0.2 
 
 
 
 SSC/0.1% SDS (1 
 
 
 
 SSC 
 
  
 
0.15 M NaCl, 0.015 M
sodium citrate, pH 7.0) at 65
 
 
 
C.
 
Detergent extraction procedures and immunoblot analysis
 
HepG2 cells grown to confluency in 100-mm dishes were rinsed with PBS
and lysed for 20 min in 1 ml of 25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5
mM EDTA, and 1% Triton X-100 at 4
 
 
 
C. Lipid rafts were prepared essen-
tially as described by Brown and Rose (1992). Fractions of 1 ml were har-
vested from the bottom of the tube, and aliquots were subjected to immu-
noblot analysis. Samples were then subjected to SDS-PAGE in 15%
acrylamide gels under reducing conditions and transferred to Immobilon-P
membranes (Millipore). After sequential incubation with the primary and
secondary antibodies, blots were developed using an ECL Western blotting
kit (Amersham Biosciences).
 
Immunofluorescence and immunohistochemical analyses
 
HepG2 cells were fixed in 4% paraformaldehyde for 15 min, rinsed, and
treated with 10 mM glycine for 5 min. The cells were then permeabilized
with 0.2% Triton X-100, rinsed, and incubated with 3% BSA in PBS for 15
min. Cells were incubated for 1 h with the indicated primary antibodies,
rinsed several times, and incubated for 1 h with the appropriate fluorescent
secondary antibodies (Southern Biotech). Controls to assess labeling speci-
ficity included incubations with control primary antibodies or omission of
the primary antibodies. As indicated in each case, images were obtained
using either a Bio-Rad Laboratories Radiance 2000 Confocal Laser micro-
scope or a conventional fluorescence microscope (ZEISS).
For immunohistochemical analysis, normal human liver tissue was fixed
for several hours in 10% neutral buffered formalin and subjected to tissue
 
processing and paraffin embedding. 5-
 
 
 
m tissue sections were blocked
with a control antibody, and then sections were sequentially incubated
with anti-MAL2 9D1 mAb and peroxidase-conjugated anti–mouse IgG an-
tibodies. Sections were developed with 0.5 mg/ml of 3,3
 
 -diaminobenzi-
dine tetrahydrochloride and hydrogen peroxide and counterstained with
hematoxylin.
Transcytosis assays
The polymeric human IgA stock employed consisted of a mixture of 70%
dimeric IgA and 30% of heavier IgA polymers, mostly trimers and tetra-
mers. IgA transcytosis was analyzed essentially as described by van IJzen-
doorn and Hoekstra (1998). Briefly, HepG2 cells stably expressing exoge-
nous pIgR were treated twice with a 100-fold excess of asialofetuin for 30
min at 4 C to block IgA internalization through asialoglycoprotein recep-
tors, and then incubated with 50  g/ml IgA at 4 C for 30 min, washed ex-
tensively, and incubated at 37 C. Under these conditions HepG2 cells ex-
pressing pIgR, but not normal HepG2 cells, were able to internalize IgA.
After cell fixation and permeabilization, IgA was detected using anti–
human IgA antibodies coupled to fluorescein. To analyze the transcytotic
transport of CD59, HepG2 cells were incubated with anti-CD59 mAb for
30 min at 4 C, washed extensively, and incubated at 37 C. Cells were
fixed and permeabilized, and the antibody bound to CD59 was detected
using a fluorescent anti–mouse IgG2a antibody.
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